Table of Contents: 1 Report Prologue 2 Market Introduction 2.1 Scope of the Study 2.2 List of Assumptions 2.3 Market Structure 3 Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.5 Forecast Model 4 Market Dynamics 4.1 Introduction 4.2 Drivers 4.2.1 Increasing prevalence of cardiovascular diseases such as heart attack & hypertension 4.2.2 Favorable reimbursement policies 4.2.3 Increasing preference for minimally invasive procedures 4.3 Restraints 4.3.1 Side-effects of anti-inflammatory drugs 4.3.2 Risk of bacterial infections 4.4 Opportunity 4.4.1 Robot-assisted surgery will be a technological milestone 4.5 Challenges 4.5.1 Expiration of blockbuster drugs 4.6 Macroeconomic indicators 4.7 Technological Trends & Assessments 5 Market Factor Analysis 5.1 Porter’s Five Forces Analysis 5.1.1 Bargaining Power of Suppliers 5.1.2 Bargaining Power of Buyers 5.1.3 Threat of New Entrants 5.1.4 Threat of Substitutes 5.1.5 Intensity of Rivalry 5.2 Supply Chain Analysis 5.2.1 R&D 5.2.2 Manufacturing 5.2.3 Distribution 5.2.4 Marketing & Sales 5.2.5 Post-Sales Monitoring 5.3 Investment Feasibility Analysis 6 Global Pericarditis Market, by Type 6.1 Introduction 6.2 Acute pericarditis 6.3 Recurrent pericarditis 6.4 Chronic pericarditis 7 Global Pericarditis Market, by Diagnosis & Treatment 7.1 Introduction 7.2 Diagnosis 7.2.1 Electrocardiogram (ECG) 7.2.2 Echocardiogram 7.2.3 Computerized tomography (CT) 7.2.4 X-Ray 7.3 Treatment 7.3.1 Medication 7.3.1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 7.3.1.2 Colchicine 7.3.2 Surgical treatment 8 Global Pericarditis Market, by End User 8.1 Introduction 8.2 Hospitals & Clinics 8.3 Medical Institutes & Research laboratories 9 Global Pericarditis Market, By Region 9.1 Introduction 9.2 Americas 9.2.1 North America 9.2.1.1 US 9.2.1.2 Canada 9.2.2 South America 9.3 Europe 9.3.1 Western Europe 9.3.1.1 Germany 9.3.1.2 France 9.3.1.3 UK 9.3.1.4 Italy 9.3.1.5 Spain 9.3.1.6 Rest of Western Europe 9.3.2 Eastern Europe 9.4 Asia-Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Middle East & Africa 9.5.1 Middle East 9.5.2 Africa 10 Competitive Landscape 10.1 Introduction 10.2 Company Ranking 11 Company Profile 11.1 Pfizer Inc. 11.1.1 Company Overview 11.1.2 Financial Overview 11.1.3 Products/Services Offered 11.1.4 Key Developments 11.1.5 SWOT Analysis 11.1.6 Key Strategies 11.2 AstraZeneca Plc 11.2.1 Company Overview 11.2.2 Financial Overview 11.2.3 Products/Services Offered 11.2.4 Key Developments 11.2.5 SWOT Analysis 11.2.6 Key Strategies 11.3 Bayer AG 11.3.1 Company Overview 11.3.2 Financial Overview 11.3.3 Products/Services Offered 11.3.4 Key Developments 11.3.5 SWOT Analysis 11.3.6 Key Strategies 11.4 Reckitt Benckiser Group Plc. 11.4.1 Company Overview 11.4.2 Financial Overview 11.4.3 Products/Services Offered 11.4.4 Key Developments 11.4.5 SWOT Analysis 11.4.6 Key Strategies 11.5 PerkinElmer, Inc. 11.5.1 Company Overview 11.5.2 Financial Overview 11.5.3 Products/Services Offered 11.5.4 Key Developments 11.5.5 SWOT Analysis 11.5.6 Key Strategies 11.6 Novartis International AG 11.6.1 Financial Overview 11.6.2 Products/Services Offered 11.6.3 Key Developments 11.6.4 SWOT Analysis 11.6.5 Key Strategies 11.7 FUJIFILM Holdings Corporation 11.7.1 Company Overview 11.7.2 Financial Overview 11.7.3 Products/Services Offered 11.7.4 Key Developments 11.7.5 SWOT Analysis 11.7.6 Key Strategies 11.8 Allergan plc. 11.8.1 Company Overview 11.8.2 Financial Overview 11.8.3 Products/Services Offered 11.8.4 SWOT Analysis 11.8.5 Key Developments 11.8.6 Key Strategies 11.9 Merck & Co., Inc. 11.9.1 Company Overview 11.9.2 Financial Overview 11.9.3 Products/Services Offered 11.9.4 Key Developments 11.9.5 SWOT Analysis 11.9.6 Key Strategies 11.1 Sanofi 11.10.1 Company Overview 11.10.2 Financial Overview 11.10.3 Products/Services Offered 11.10.4 Key Developments 11.10.5 SWOT Analysis 11.10.6 Key Strategies 11.11 Johnson & Johnson Services, Inc. 11.11.1 Company Overview 11.11.2 Financial Overview 11.11.3 Products/Services Offered 11.11.4 Key Developments 11.11.5 SWOT Analysis 11.11.6 Key Strategies 12 Appendix 12.1 Discussion Blue Print

List of Tables: TABLE 1 MARKET SYNOPSIS 15 TABLE 2 LIST OF ASSUMPTIONS 17 TABLE 3 GLOBAL PERICARDITIS MARKET, BY TYPE 2015-2023 (USD MILLION) 35 TABLE 4 GLOBAL PERICARDITIS MARKET FOR ACUTE PERICARDITIS, BY REGION 2015-2023 (USD MILLION) 36 TABLE 5 GLOBAL PERICARDITIS MARKET FOR ACUTE PERICARDITIS, BY REGION 2015-2023 (USD MILLION) 37 TABLE 6 GLOBAL PERICARDITIS MARKET FOR ACUTE PERICARDITIS, BY REGION 2015-2023 (USD MILLION) 38 TABLE 7 GLOBAL PERICARDITIS MARKET, BY DIAGNOSIS & TREATMENT 2015-2023 (USD MILLION) 40 TABLE 8 GLOBAL PERICARDITIS MARKET FOR DIAGNOSIS, BY TYPE 2015-2023 (USD MILLION) 41 TABLE 9 GLOBAL PERICARDITIS MARKET FOR DIAGNOSIS, BY REGION 2015-2023 (USD MILLION) 41 TABLE 10 GLOBAL PERICARDITIS MARKET FOR ELECTROCARDIOGRAM (ECG), BY REGION 2015-2023 (USD MILLION) 42 TABLE 11 GLOBAL PERICARDITIS MARKET FOR ECHOCARDIOGRAM, BY REGION 2015-2023 (USD MILLION) 43 TABLE 12 GLOBAL PERICARDITIS MARKET FOR CT, BY REGION 2015-2023 (USD MILLION) 43 TABLE 13 GLOBAL PERICARDITIS MARKET FOR X-RAY, BY REGION 2015-2023 (USD MILLION) 44 TABLE 14 GLOBAL PERICARDITIS MARKET FOR TREATMENT, BY TYPE 2015-2023 (USD MILLION) 45 TABLE 15 GLOBAL PERICARDITIS MARKET FOR TREATMENT, BY REGION 2015-2023 (USD MILLION) 45 TABLE 16 GLOBAL PERICARDITIS MARKET FOR MEDICATION, BY TYPE 2015-2023 (USD MILLION) 46 TABLE 17 GLOBAL PERICARDITIS MARKET FOR MEDICATION, BY REGION 2015-2023 (USD MILLION) 46 TABLE 18 GLOBAL PERICARDITIS MARKET FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION 2015-2023 (USD MILLION) 47 TABLE 19 GLOBAL PERICARDITIS MARKET FOR COLCHICINE, BY REGION 2015-2023 (USD MILLION) 47 TABLE 20 GLOBAL PERICARDITIS MARKET FOR SURGICAL TREATMENT, BY REGION 2015-2023 (USD MILLION) 48 TABLE 21 GLOBAL PERICARDITIS MARKET, BY END-USER 2015-2023 (USD MILLION) 50 TABLE 22 GLOBAL PERICARDITIS MARKET FOR HOSPITALS & CLINICS, BY REGION 2015-2023 (USD MILLION) 51 TABLE 23 GLOBAL PERICARDITIS MARKET FOR MEDICAL INSTITUTES & RESEARCH LABORATORIES, BY REGION 2015-2023 (USD MILLION) 52 TABLE 24 GLOBAL PERICARDITIS MARKET, BY REGION 2015-2023 (USD MILLION) 55 TABLE 25 AMERICAS PERICARDITIS MARKET BY REGION, 2015 TO 2023 (USD MILLION) 56 TABLE 26 AMERICAS PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 57 TABLE 27 AMERICAS PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 57 TABLE 28 AMERICAS PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 58 TABLE 29 AMERICAS PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 58 TABLE 30 AMERICAS PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 59 TABLE 31 AMERICAS PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 59 TABLE 32 NORTH AMERICA PERICARDITIS MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 60 TABLE 33 NORTH AMERICA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 60 TABLE 34 NORTH AMERICA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 61 TABLE 35 NORTH AMERICA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 61 TABLE 36 NORTH AMERICA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 61 TABLE 37 NORTH AMERICA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 62 TABLE 38 NORTH AMERICA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 62 TABLE 39 US PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 63 TABLE 40 US PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 63 TABLE 41 US PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 63 TABLE 42 US PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 64 TABLE 43 US PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 64 TABLE 44 US PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 65 TABLE 45 CANADA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 66 TABLE 46 CANADA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 66 TABLE 47 CANADA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 66 TABLE 48 CANADA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 67 TABLE 49 CANADA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 67 TABLE 50 CANADA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 68 TABLE 51 SOUTH AMERICA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 68 TABLE 52 SOUTH AMERICA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 69 TABLE 53 SOUTH AMERICA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 69 TABLE 54 SOUTH AMERICA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 70 TABLE 55 SOUTH AMERICA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 70 TABLE 56 SOUTH AMERICA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 71 TABLE 57 EUROPE PERICARDITIS MARKET BY REGION, 2015 TO 2023 (USD MILLION) 72 TABLE 58 EUROPE PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 73 TABLE 59 EUROPE PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 73 TABLE 60 EUROPE PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 73 TABLE 61 EUROPE PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 74 TABLE 62 EUROPE PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 74 TABLE 63 EUROPE PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 75 TABLE 64 WESTERN EUROPE PERICARDITIS MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 76 TABLE 65 WESTERN EUROPE PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 76 TABLE 66 WESTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 77 TABLE 67 WESTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 77 TABLE 68 WESTERN EUROPE PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 77 TABLE 69 WESTERN EUROPE PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 78 TABLE 70 WESTERN EUROPE PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 78 TABLE 71 GERMANY PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 79 TABLE 72 GERMANY PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 79 TABLE 73 GERMANY PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 79 TABLE 74 GERMANY PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 80 TABLE 75 GERMANY PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 80 TABLE 76 GERMANY PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 81 TABLE 77 FRANCE PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 81 TABLE 78 FRANCE PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 81 TABLE 79 FRANCE PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 82 TABLE 80 FRANCE PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 82 TABLE 81 FRANCE PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 83 TABLE 82 FRANCE PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 83 TABLE 83 UK PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 84 TABLE 84 UK PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 84 TABLE 85 UK PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 84 TABLE 86 UK PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 85 TABLE 87 UK PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 85 TABLE 88 UK PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 86 TABLE 89 ITALY PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 86 TABLE 90 ITALY PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 86 TABLE 91 ITALY PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 87 TABLE 92 ITALY PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 87 TABLE 93 ITALY PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 88 TABLE 94 ITALY PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 88 TABLE 95 SPAIN PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 89 TABLE 96 SPAIN PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 89 TABLE 97 SPAIN PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 89 TABLE 98 SPAIN PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 90 TABLE 99 SPAIN PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 90 TABLE 100 SPAIN PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 91 TABLE 101 REST OF WESTERN EUROPE PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 91 TABLE 102 REST OF WESTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 91 TABLE 103 REST OF WESTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 92 TABLE 104 REST OF WESTERN EUROPE PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 92 TABLE 105 REST OF WESTERN EUROPE PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 93 TABLE 106 REST OF WESTERN EUROPE PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 93 TABLE 107 EASTERN EUROPE PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 94 TABLE 108 EASTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 94 TABLE 109 EASTERN EUROPE PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 95 TABLE 110 EASTERN EUROPE PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 95 TABLE 111 EASTERN EUROPE PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 96 TABLE 112 EASTERN EUROPE PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 96 TABLE 113 ASIA-PACIFIC PERICARDITIS MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 97 TABLE 114 ASIA-PACIFIC PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 98 TABLE 115 ASIA-PACIFIC PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 98 TABLE 116 ASIA-PACIFIC PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 98 TABLE 117 ASIA-PACIFIC PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 99 TABLE 118 ASIA-PACIFIC PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 99 TABLE 119 ASIA-PACIFIC PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 100 TABLE 120 JAPAN PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 100 TABLE 121 JAPAN PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 100 TABLE 122 JAPAN PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 101 TABLE 123 JAPAN PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 101 TABLE 124 JAPAN PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 101 TABLE 125 JAPAN PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 102 TABLE 126 CHINA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 102 TABLE 127 CHINA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 103 TABLE 128 CHINA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 103 TABLE 129 CHINA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 103 TABLE 130 CHINA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 104 TABLE 131 CHINA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 104 TABLE 132 INDIA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 105 TABLE 133 INDIA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 105 TABLE 134 INDIA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 106 TABLE 135 INDIA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 106 TABLE 136 INDIA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 106 TABLE 137 INDIA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 107 TABLE 138 AUSTRALIA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 108 TABLE 139 AUSTRALIA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 108 TABLE 140 AUSTRALIA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 109 TABLE 141 AUSTRALIA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 109 TABLE 142 AUSTRALIA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 109 TABLE 143 AUSTRALIA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 110 TABLE 144 SOUTH KOREA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 111 TABLE 145 SOUTH KOREA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 111 TABLE 146 SOUTH KOREA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 112 TABLE 147 SOUTH KOREA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 112 TABLE 148 SOUTH KOREA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 112 TABLE 149 SOUTH KOREA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 113 TABLE 150 REST OF ASIA PACIFIC PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 114 TABLE 151 REST OF ASIA PACIFIC PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 114 TABLE 152 REST OF ASIA PACIFIC PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 115 TABLE 153 REST OF ASIA PACIFIC PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 115 TABLE 154 REST OF ASIA PACIFIC PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 115 TABLE 155 REST OF ASIA PACIFIC PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 116 TABLE 156 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY REGION, 2015 TO 2023 (USD MILLION) 117 TABLE 157 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 118 TABLE 158 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 118 TABLE 159 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 118 TABLE 160 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 119 TABLE 161 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 119 TABLE 162 MIDDLE EAST & AFRICA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 120 TABLE 163 MIDDLE EAST PERICARDITIS MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 121 TABLE 164 MIDDLE EAST PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 121 TABLE 165 MIDDLE EAST PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 122 TABLE 166 MIDDLE EAST PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 122 TABLE 167 MIDDLE EAST PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 122 TABLE 168 MIDDLE EAST PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 123 TABLE 169 AFRICA PERICARDITIS MARKET BY DIAGNOSIS & TREATMENT, 2015 TO 2023 (USD MILLION) 124 TABLE 170 AFRICA PERICARDITIS MARKET BY DIAGNOSIS TYPE, 2015 TO 2023 (USD MILLION) 125 TABLE 171 AFRICA PERICARDITIS MARKET BY TREATMENT TYPE, 2015 TO 2023 (USD MILLION) 125 TABLE 172 AFRICA PERICARDITIS MARKET BY MEDICATION TYPE, 2015 TO 2023 (USD MILLION) 125 TABLE 173 AFRICA PERICARDITIS MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 126 TABLE 174 TOP MANUFACTURERS IN THE GLOBAL PERICARDITIS MARKET 128List of Figures: FIGURE 1 GLOBAL PERICARDITIS MARKET: MARKET STRUCTURE 18 FIGURE 2 RESEARCH PROCESS OF MRFR 20 FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 23 FIGURE 4 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL PERICARDITIS MARKET 30 FIGURE 5 SUPPLY CHAIN: PERICARDITIS MARKET 32 FIGURE 6 GLOBAL PERICARDITIS MARKET, BY TYPE 2017 & 2023 35 FIGURE 7 GLOBAL PERICARDITIS MARKET, BY DIAGNOSIS & TREATMENT 2017 & 2023 40 FIGURE 8 GLOBAL PERICARDITIS MARKET, BY END-USER 2017 & 2023 50 FIGURE 9 GLOBAL PERICARDITIS MARKET BY REGION, 2017 & 2023 (USD MILLION) 54 FIGURE 10 AMERICAS PERICARDITIS MARKET SHARE, BY REGION, 2017 (%) 56 FIGURE 11 NORTH AMERICA PERICARDITIS MARKET SHARE BY REGION, 2017 (%) 60 FIGURE 12 EUROPE PERICARDITIS MARKET SHARE BY REGION, 2017 (%) 72 FIGURE 13 WESTERN EUROPE PERICARDITIS MARKET SHARE BY COUNTRY, 2017 (%) 75 FIGURE 14 ASIA-PACIFIC PERICARDITIS MARKET SHARE BY REGION, 2017 (%) 97 FIGURE 15 MIDDLE EAST & AFRICA PERICARDITIS MARKET SHARE BY REGION, 2017 (%) 117

FUJIFILM Holdings Corporation, Bayer AG, Merck & Co., Inc. and Allergan plc, Novartis International AG, Pfizer Inc., AstraZeneca Plc., PerkinElmer, Inc., Sanofi, Johnson & Johnson Services, Inc., Reckitt Benckiser Group Plc